These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30010736)

  • 21. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.
    Jonkers D; Penders J; Masclee A; Pierik M
    Drugs; 2012 Apr; 72(6):803-23. PubMed ID: 22512365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.
    Burisch J; Weimers P; Pedersen N; Cukovic-Cavka S; Vucelic B; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Valpiani D; Boni MC; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Sanroman L; Almer S; Zhulina Y; Halfvarson J; Arebi N; Diggory T; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    J Crohns Colitis; 2014 Sep; 8(9):1030-42. PubMed ID: 24560877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.
    Feagan BG; Patel H; Colombel JF; Rubin DT; James A; Mody R; Lasch K
    Aliment Pharmacol Ther; 2017 Jan; 45(2):264-275. PubMed ID: 27859410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Previous experience and quiality of life in patients with inflammatory bowel disease during relapse.
    Casellas F; López Vivancos J; Malagela JR
    Rev Esp Enferm Dig; 2003 Jul; 95(7):476-9, 471-5. PubMed ID: 12952508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life.
    Paschos P; Katsoula A; Salanti G; Giouleme O; Athanasiadou E; Tsapas A
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1174-1185. PubMed ID: 30378141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological aspect of patients with inflammatory bowel disease, which may be related to the quality of life, sleep and disease characteristics.
    Ling F; Tu L; Li J; Chen Y; Xu M; Zhu L
    Scand J Gastroenterol; 2021 Nov; 56(11):1328-1336. PubMed ID: 34448648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnaire.
    Pallis AG; Vlachonikolis IG; Mouzas IA
    Digestion; 2001; 63(4):240-6. PubMed ID: 11435724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of inflammatory bowel disease on different dimensions of quality of life.
    Casellas F; López-Vivancos J; Badia X; Vilaseca J; Malagelada JR
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):567-72. PubMed ID: 11396538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients.
    Bastida G; Nos P; Aguas M; Beltrán B; Iborra M; Ortiz V; Garrigues V; Estevan R; Ponce J
    BMC Gastroenterol; 2010 Mar; 10():26. PubMed ID: 20196836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of upadacitinib induction and maintenance therapy on health-related quality of life, fatigue, and work productivity in patients with moderately-to-severely active Crohn's disease.
    Ghosh S; Feagan BG; Parra RS; Lopes S; Steinlauf A; Kakuta Y; Joshi N; Lee WJ; Lacerda AP; Zhou Q; Xuan S; Kligys K; Shukla N; Louis E
    J Crohns Colitis; 2024 Jun; ():. PubMed ID: 38835235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; Wang Y; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006618. PubMed ID: 25162749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis.
    Dubinsky MC; Jairath V; Feagan BG; Naegeli AN; Tuttle J; Morris N; Shan M; Arora V; Lissoos T; Agada N; Hibi T; Sands BE
    BMJ Open Gastroenterol; 2023 Mar; 10(1):. PubMed ID: 37001911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation Between Sleep, Life, Mood, and Diet and Severity of Inflammatory Bowel Disease in China: A Retrospective Study.
    Xu J; Chen X; Ma K; Nie K; Luo W; Wu X; Pan S; Wang X
    Med Sci Monit; 2021 Aug; 27():e930511. PubMed ID: 34370718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life.
    Palm Ø; Bernklev T; Moum B; Gran JT
    J Rheumatol; 2005 Sep; 32(9):1755-9. PubMed ID: 16142874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials.
    Ben-Horin S; Novack L; Mao R; Guo J; Zhao Y; Sergienko R; Zhang J; Kobayashi T; Hibi T; Chowers Y; Peyrin-Biroulet L; Colombel JF; Kaplan GG; Chen MH
    Gastroenterology; 2022 Feb; 162(2):482-494. PubMed ID: 34757139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.